The Hindu

Sharp cuts in price of cancer drugs expose excessive pricing, say health experts

NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effectivefrom November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patients ability to pay